Previous 10 | Next 10 |
Cerecor (NASDAQ: CERC ) and Myriad Genetics (NASDAQ: MYGN ) announce that levels of a novel cytokine called LIGHT is highly correlated with disease severity and mortality in COVID-19 patients with acute respiratory distress syndrome (ARDS). The data were generated in a biomarker stud...
- Patients hospitalized with COVID-19 had significantly elevated levels of the inflammatory cytokine LIGHT - LIGHT was strongly linked with mortality (82%) in patients over 60 years of age - Decreasing LIGHT levels using CERC-002 (anti-LIGHT mAb) may prevent cytokine storm induced seve...
Cerecor (NASDAQ: CERC ): Q1 GAAP EPS of -$0.36 misses by $0.26 . More news on: Cerecor Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Significantly Improved Cash Position and Balance Sheet Closed Aevi Merger; Transformed into Orphan and Rare Disease Biotech ROCKVILLE, Md., May 07, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and...
-Appoints Sol J. Barer, Ph.D. as Chairman of the Board - Appoints Suzanne Bruhn, Ph.D. and Joseph Miller as Directors to the Board ROCKVILLE, Md., April 24, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and co...
Aytu BioScience, Inc. (NASDAQ: AYTU ) has had a wild ride in March, going from a tiny penny stock to a company many are looking at in this coronavirus pandemic as a potential testing investment. I am not convinced by the long-term prospects of AYTU after the coronavirus scare settles down and ...
Cerecor (NASDAQ: CERC ) will explore the role of an inflammatory cytokine, LIGHT, in patients with COVID-19 induced Acute Respiratory Distress. More news on: Cerecor Inc., Healthcare stocks news, Stocks on the move, Read more ...
ROCKVILLE, Md., March 26, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, today announces that it will explore the role of an inflammator...
"I always cheer up immensely if an attack is particularly wounding because I think, well, if they attack one personally, it means they have not a single political argument left. " - Margaret Thatcher Today, we look at a " Tier 4 " biotech concern with multiple " shots on goal ". Like so m...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
News, Short Squeeze, Breakout and More Instantly...
Cerecor Inc. Company Name:
CERC Stock Symbol:
NASDAQ Market:
WAYNE, Pa. and ROCKVILLE, Md., July 16, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Mittie Doyle, MD, FACR has joined the Company as its Chief Medical Officer. “We are thrilled to have Mittie join and grow our leadership team at an exciting...
Following FDA review, Avalo’s IND application for AVTX-009 is active allowing Avalo to proceed with its Phase 2 trial (LOTUS) to evaluate the efficacy and safety of AVTX-009 in patients with hidradenitis suppurativa WAYNE, Pa. and ROCKVILLE, Md., July 09, 2024 (GLOBE NEWSWIRE) -- Ava...
WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present on the Novel Immunological Mechanisms for Dermatological Disorders Panel being held at...